A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Tobramycin Peak
Test CodeCPT Codes
80200
Preferred Specimen
Serum (gold top) tube
Minimum Volume
Other Acceptable Specimens
Instructions
To obtain a serum tobramycin concentration that best represents the peak tissue level, draw the sample one hour after an intramuscular injection, 30 minutes after ending a 30- minute intravenous infusion, or immediately after a 60-minute intravenous infusion. Collect a trough sample just before the next scheduled dose. When adjusting dosage, measure peak and trough levels during the same dosing intervals.
Transport Container
Serum (gold top) tube or Lithium Heparin Plasma (green top) tube
Transport Temperature
Specimen Stability
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Photometric
Setup Schedule
Daily upon receipt
Report Available
Limitations
Reference Range
No reference range given for peak Tobramycin..
Critical range: 24.0 ug/mL or higher
Clinical Significance
Tobramycin is used in the treatment of serious infections caused by susceptible strains of gram-negative microorganisms and particular gram-positive organisms that are resistant to less toxic antibiotics. Tobramycin is safe and effective only in a narrow range of concentrations for a given indication. Exposure to high tobramycin concentrations for a prolonged period may cause renal impairment or ototoxicity. Serum or plasma tobramycin measurements are used in the diagnosis and treatment of tobramycin overdose and in monitoring levels of tobramycin to ensure appropriate therapy.